How to buy Certara (CERT.US) stock | finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Certara stock

Own Certara stock in just a few minutes.

Certara, headquartered in Princeton, NJ, produces model-based pharmaceutical software.

How to buy shares in Certara

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Certara. Find the stock by name or ticker symbol: CERT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Certara reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Certara, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Certara. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Certara share price

Use our graph to track the performance of CERT stocks over time.

Certara shares at a glance

Information last updated 2021-04-08.
52-week rangeUSD$23 - USD$41.79
50-day moving average USD$30.466
200-day moving average USD$33.5579
Wall St. target priceUSD$36
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Certara shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Certara stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Certara under- or over-valued?

Valuing Certara stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Certara's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Certara's EBITDA

Certara's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$20.9 million.

The EBITDA is a measure of a Certara's overall financial performance and is widely used to measure a its profitability.

To put Certara's EBITDA into context you can compare it against that of similar companies.

Certara financials

Revenue TTM USD$243.5 million
Gross profit TTM USD$142.8 million
Return on assets TTM -1.18%
Return on equity TTM -7.52%
Profit margin -20.28%
Book value N/A
Market capitalisation USD$4.2 billion

TTM: trailing 12 months

Shorting Certara shares

There are currently 1.6 million Certara shares held short by investors – that's known as Certara's "short interest". This figure is 7.8% down from 1.7 million last month.

There are a few different ways that this level of interest in shorting Certara shares can be evaluated.

Certara's "short interest ratio" (SIR)

Certara's "short interest ratio" (SIR) is the quantity of Certara shares currently shorted divided by the average quantity of Certara shares traded daily (recently around 675663.91304348). Certara's SIR currently stands at 2.3. In other words for every 100,000 Certara shares traded daily on the market, roughly 2300 shares are currently held short.

To gain some more context, you can compare Certara's short interest ratio against those of similar companies.

However Certara's short interest can also be evaluated against the total number of Certara shares, or, against the total number of tradable Certara shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Certara's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Certara shares in existence, roughly 10 shares are currently held short) or 0.0241% of the tradable shares (for every 100,000 tradable Certara shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Certara.

Find out more about how you can short Certara stock.

Certara share dividends

We're not expecting Certara to pay a dividend over the next 12 months.

You may also wish to consider:

Certara overview

Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site